Cipla, INE059A01026

Macquarie raises target for Cipla stock from INR 1,675 to INR 1,730

Published on 10/19/2026 at 10:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
JPMorgan keeps an Overweight view with an INR 1,600 target. Cipla stock faces second-quarter results on October 27. First-quarter net income fell 39.00 percent on 3.50 percent revenue growth.

Analyst view and reporting dates

  • Macquarie raised its Cipla target to INR 1,730 on October 7, 2026.
  • Cipla reported INR 70.8 billion in first-quarter fiscal 2027 revenue and INR 7.89 billion in net income.
  • Cipla's board is scheduled to consider second-quarter results on October 27, 2026.
  • Cipla's market capitalization stood at INR 1.1 trillion on October 19, 2026.
Cipla, INE059A01026, Illustration mit AI erstellt.

Cipla (ISIN INE059A01026) has a new INR 1,730 price target after Macquarie raised its target from INR 1,675 on October 7, 2026, according to Investing.com. The revision puts the brokerage view above Cipla's October 19 NSE quote of INR 1,328.70 at 1:07 p.m. IST. The next results date gives the target change an immediate test.

What does the target change signal?

Macquarie's revised target sits alongside JPMorgan's Overweight rating and INR 1,600 target, reported by The Financial Express on October 7, 2026. JPMorgan expects India growth of 12.00 percent in the September quarter and US growth of 7.00 percent, while the main counter-factor is pressure in US generics.

The operating backdrop is uneven. Cipla's first-quarter fiscal 2027 revenue rose 3.50 percent to INR 70.8 billion, while net income fell 39.00 percent to INR 7.89 billion, according to Simply Wall St. The reported profit margin was 11.00 percent, down from 19.00 percent in the comparable quarter, with higher expenses cited as the driver.

Three dates shape the story

On July 24, 2026, Cipla reported first-quarter fiscal 2027 revenue of INR 70.8 billion; on October 7, 2026, Macquarie raised its target from INR 1,675 to INR 1,730; and on October 27, 2026, the company is scheduled to consider second-quarter results. The first two events frame the central question: whether earnings can close the gap between revenue growth and profit.

Results arrive October 27

Cipla's board meeting on October 27, 2026 covers unaudited results for the quarter and half-year ended September 30, 2026, according to Bsenexus. The September-quarter outcome will show whether domestic demand can offset US pricing pressure and whether margins move closer to the company's recent operating expectations.

NSE quote and valuation

Cipla was quoted at INR 1,328.70 on the NSE on October 19, 2026 at 1:07 p.m. IST. The stock's 52-week range was INR 1,165.70 to INR 1,673.00, while market capitalization stood at INR 1.1 trillion on October 19, 2026.

Cipla stock key facts

  • Company: Cipla Limited
  • ISIN: INE059A01026
  • Ticker: CIPLA
  • Primary exchange: NSE
  • Price NSE (as of October 19, 2026, 1:07 p.m. IST): INR 1,328.70
  • Market capitalization: INR 1.1 trillion (as of October 19, 2026)
  • 52-week range: INR 1,165.70-1,673.00 (as of October 19, 2026)
  • Sector / Industry: Healthcare / Pharmaceuticals
  • Index membership: NIFTY 50

Market context: Market report BSE Sensex.

More news and analyses on Cipla stock

Disclaimer...
en | INE059A01026 | CIPLA | boerse | 70360797 | bgmi